Subject index

Key and Abbreviations: A refers to the page number, followed by the abstract number.

18F-Fluoride Positron Emission Tomography A82 117 CAD /coronary angiography A144 218 CT A82 118 2D speckle tracking echo A144 218 Calcium A82 118 CT Coronary Angiography A63 89 6 weeks A12 19 Cancer A57 79 Capillary rarefaction A66 93 day case A38 53 Ablation A46, A47, A49 63, 65, 68 Carcinoid disease A89 126 developmental programming A135 202 ACS A73, A77 104, 109 A75 106 Diabetes A132, A132 195, 196 Actin cytoskeleton A135 201 cardiac fibrosis A117 166 Diabetes Type II A78 110 Acute coronary syndome A70, A72, A76 99, 102, Cardiac Function A131 193 Diabetic Cardiomyopathy A128 187 107 cardiac magnetic resonance A91 129 diagnostic accuracy A94 132 Acute Medical admission A109 150 cardiac magnetic resonance imaging A81, A81, Diagnostics A50 69 Acute myocardial A114, A19, A69 160, A88 114, 115, 125 Diffusion A96 134 28, 98 Cardiac MRI A89, A125, A28 126, 182, 40 Dilated Cardiomyopathy A7, A87, A102, A103 10, Adult Congenital heart disease A54 75 Cardiac Physiologists A42 58 124, 142, 143 Adult congenital Heart services A52 71 Cardiac Resynchronisation Therapy A2, A39, A39 Direct Flow Medical valve A32 45 AECU A92, A50 130, 70 2, 54, 55 Disarray A96 134 AF A143, A36 217, 50 cardiac-coronary interaction A66 94 discharge rates A68 96 Ageing A114, A128, A142 159, 188, 215 Cardiogoniometry A67 95 Dkk3 A146 B All-cause mortality A13 21 Cardiomyopathy A108, A138 149, 209 Door to Balloon Times A18 27 ALSTROM A96 135 cardioprotection A115 162 Droplet microfluidics A129 190 Ambulatory A50 70 Cardiosphere-derived cells A116 164 Ambulatory care A92 130 Cardiotoxicity A14 23 ECG A41 57 Anaemia A76 107 Cardiovascular Comorbidities A74, A55 105, 77 ECGi A105 146 angina A64 90 Cardiovascular Disease A132, A61 196, 85 Echocardiogram A89, A10 127, 15 Angiogenesis A132, A134 195, 199 Cardiovascular imaging A81 116 A83, A85, A90, A92, A110, angiography A75 106 Cardiovascular Magnetic Resonance A26 38 A111, A26 119, 120, 128, 130, 152, 153, 37 Angiotensin A137 207 Cardiovascular Risk A60, A61 83, 84 ECV A96 135 Anterior T wave inversion A108 149 care A71 101 eHealth A60 83 Anthracyclines A89 127 Carelink A43 59 Elderly A101, A45 140, 61 Anticoagulation A25, A35, A45 36, 49, 61 carotid intimal medial thickness A144 218 Electrocardiogram (ECG) A42, A86, A108 58, 121, Antioxidants A129 189 carotid plaque A93 131 149 antithrombotic therapies A118 169 A47 64 Electrode Position A42 58 A101, A126 141, 183 Caveolin A123 178 ELN gene A135 203 Aortic Regurgitation A28 40 Cell therapy A118 168 Endocardial LV pacing A41 56 Aortic Stenosis A82, A9, A109, A113, A140, CHADSVASC A54 75 Endocarditis A100 139 A143, A26, A30, A31, A34 117, 13, 151, Chemotherapy A14 23 ENDOTHELIAL CELL A115 163 158, 212, 216, 37, 41, 43, 47 Chest pain A58 81 Endothelial Cells A134, A136 200, 205 Aortic Valve A100, A113 139, 157 CIMT A66 92 endothelial dysfunction A117, A136, A39 167, Aortic A101, A111, A26 141, CLARIFY A58 80 204, 54 153, 38 Clinical Exome A139 210 Endothelial progenitor cells A22 32 Aortopathy A97, A53 136, 73 clinical impact A91 129 endothelial-mesenchymal transition A117 166 apical HCM A104 144 clinical predictors A39 55 Erythropoietin A130 192 Arrhythmia A41 57 Clot lysis time A78 110 ESC Risk Sscore A104 145 arterial access site A24 34 CMR A104, A16, A30, A30 144, 25, 41, 42 Ethnicity A12, A56 20, 78 atherosclerosis A121, A121, A123, A128, A130, Coarctation of aorta A52 71 Euroscore A31 43 A131, A132, A137, A142 173, 174, 179, 188, Cold air inhalation A20 30 Exercise A88, A20 125, 30 191, 194, 197, 206, 214 complex cardiac disease A139 210 Exosomes A115 162 Athletes Heart A85, A86 120, 121 complication A38 53 Extracellular matrix A127 185 ATP A130 191 Complications A46 63 EXTRACELLULAR VESICLES A115 163 Atrial Fibrillation A7, A98, A127, A13, A34, Computational Fluid Dynamics A126 183 A35, A44, A45, A45, A46, A47, A47, A54 Computed Tomography A82, A95 117, 133 Familial DCM A103 143 11, 138, 185, 21, 48, 49, 60, 61, 62, 63, 64, Congenital Heart Disease A52 72 feature tracking A30 42 65, 75 consultant-led service A68 96 Ferritin A131 194 A119 170 Contractile reserve A140 212 ffr A94, A19 132, 29 Audit A55 76 Contrast induced nephropathy A138 208 fibrin clot A127 186 Aurintricarboxylic Acid A134 199 Copy Number Variants A135 203 Fibroblast Growth Factor 23 A131 193 Autopsy A141 213 CORM-A1 A114 160 FIBROSIS A96 135 Coronary angiography A72, A95 102, 133 Flow Mediated Dilation A39 54 B Cells A137 206 A82, A93, A95, A125, Follow-up A37 52 Beta3-adrenoceptors A114 161 A58, A67, A145 118, 131, 133, 181, 80, 95, A Fontan A54 74 Bicuspid Valve Disease A101 141 coronary flow reserve A120 172 Force Frequency Relations A140 212 Biomarkers A9, A109, A138, A143, A144 13, Coronary microvascular resistance A20 30 frusemide lounge A6 9 151, 208, 217, 219 Coronary Physiology A21, A146 31, D Functional status A33 46 Bleeding A25 36 coronary wave intensity analysis A66 94 BNP A10, A113, A10 15, 158, 16 CPEX A54 74 Gender A17 26 Brugada Syndrome A105 146 CRT A41 56 general anaesthesia A32 44 genetics A87, A97 124, 136

A148 Heart 2016;102(Suppl 6):A1–A156 Subject index

Global longitudinal strain A90, A66 128, 92 Long QTc interval A109 150 Nstemi A62 86 glycomimetic A136 204 Long Term Outcomes A80 113 NT-proBNP A143 217 GRACE A73 104 Low density lipoprotein A131 194 Nuclear cardiology A81 116 Grip Strength A2 2 low flow A111 153 nuclear imaging A86 122 guidelines A61 84 low risk A58 81 nursing A71 101 GWAS A145 A LV Stroke Volume A30 41 Obesity A114, A123, A135, A49 161, 178, 202, 67 haemodialysis patients A90 128 Macrophage A116 165 Out of hospital cardiac arrest A72 102 Haemorheology A142 214 Magnetic resonance A98 138 outcomes A6 8 hand-held echocardiography A113 157 management A36 50 Outgrowth Endothelial Cells A132 195 HCM A106 147 Marfan syndrome A53 73 Outpatient A58, A6 81, 9 HDAC A117 166 Marital status A77 108 Oxidative stress A114, A117, A136 159, 167, 204 HDAC7 A122 176 maternal obesity A125 180 health economics A106 148 Mehran score A138 208 P2Y12 Inhbitors A77, A78 109, 111 Heart Age A60 83 Mental Stress A21 31 pacemaker A34, A37, A43 48, 52, 59 heart failure A1, A7, A8, A89, A9, A10, A10, meta-analysis A24 35 Pacing A38 53 A11, A12, A13, A14, A15, A2, A3, A4, Microcirculation A66 93 Paradoxical embolism A97 137 A5, A6, A6 1, 11, 12, 127, 13, 15, 16, 17, 20, microparticles A122 177 Patent foramen ovale A97 137 21, 22, 24, 3, 4, 5, 6, 8, 9 microRNA A121, A132, A133, A147 173, 197, pathway A36 50 hedgehog signalling A145 A 198, E percutaneous coronary intervention A24, A25 34, heterogeneous nuclear ribonucleoprotein A1 A121 microvascular dysfunction A120 172 36 174 migration A122 176 Perfusion defect A62 87 Hexarelin A127 184 mineralocorticoid receptor antagonist A14 22 perfusion scintigraphy A86 122 HF outcomes A6 7 minimally invasive A112 156 Perioperative A62 88 H-FABP A144 219 MINS A62 88 Perivascular adipose tissue A114, A135 161, 202 HFPEF A15, A16 24, 25 MITOCHONDRIA A120 171 Personalised Medicine A134 200 HFREF A15 24 Mitochondrial Dysfunction A128 187 phosphorylation A122 176 high-sensitity troponin A72 103 Mitofusin-2 A128 187 Physiologists A50 69 Histiocytoid A138 209 mitral A112 156 plakoglobin A119 170 Histopathology A48 66 Mitral Valve A101, A112 140, 154 Plaque A116 165 hospitalised patients A91 129 mitral valve prolapse A112 155 Plaque stability A146 B HSP70 A115 162 A101 140 platelet A127 186 hsTnT A144 219 mode switch A34 48 Platelet closure times A143 216 Hyperlipidaemia A57 79 Morbidity and Mortality A52 71 Platelet Function A77, A78 109, 111 Hyperoxia A146 D Morphine A19 28 Platelets A129 190 A66 93 Mortality A74, A76, A77, A8, A12, A24, A3, PMCA4 A134 199 Hypertrophic Cardiomyopathy A7, A96, A104, A44, A55, A56, A57 105, 107, 108, 12, 19, Polarisation A116 165 A104, A106 10, 134, 144, 145, 147 34, 4, 60, 77, 78, 79 positive predictive value A79 112 hyponatraemia A1 1 Multiscale Model A142 214 positron emission tomography A87 123 hypoxia A130 192 Multivessel disease A68 97 Postconditioning A137 207 myocardial A86 122 PPCI A71, A17, A68 101, 26, 97 IFR A19 29 myocardial fibrosis A112 155 Pregnancy A122, A53 175, 73 IgM A137 206 myocardial haemorrhage A81 114 Preload A83 119 Implantable Cardiac defibrillator A49 68 myocardial infarction A72, A79, A8, A115, A116, pre-participation screening A106 148 implantable cardioverter defibrillator A37 51 A120, A127, A131, A14, A26, A70 103, preserved ejection fraction A2 3 Improving Outcomes A9 14 112, 12, 163, 164, 171, 184, 193, 22, 38, 99 Pressure Myography A129 189 Incidence A141 213 Myocardial Injury A80 113 Prevention A59, A62 82, 86 inflammation A87, A114, A122, A127 123, 160, Myocardial Ischaemia A21 31 Primary PCI A18 27 175, 184 myocardial oedema A81 115 Primary Percutaneous Coronary Intervention A70, Innovation A50 69 Myocardial Perfusion Imaging A146 D A19, A69 100, 28, 98 Integration A5 6 Myocardial perfusion scintigraphy A81 116 primary prevention A61 84 Intrinsic variation A129 190 myocarditis A87 123 Prognosis A12, A12, A16, A62, A64 18, 20, 25, iPS Cells A136 205 myosin binding protein C A109 151 87, 90 ischemia A133 198 programming A125, A37 180, 51 Ischemia reperfusion A137 207 NADPH oxidase A117 167 Proliferation A118, A140 168, 211 LBBB A70 99 NADPH oxidases A136 205 prostagrandin A120 172 left atrial appendage A45 62 Neuroimaging A123 179 Prosthesis A100 139 Left bundle branch block A27 39 Neurovascular A97, A123 136, 179 Proteomics A125, A127 181, 185 Left main stem disease A23 33 New diagnosed A11 17 Psychiatric comorbidities A7, A4 10, 5 Left ventricular Dysfunction A14 23 next generation sequencing A87, A139 124, 210 psychiatric disease A55 77 Left ventricular ejection fraction A27 39 nf-kb A140 211 Pulmonary Arterial Hypertension A52 72 Left ventricular hypertrophy A49 67 NICE Adherance A9 14 systolic pressure A33 46 Left ventricular pressure-volume loop A66 94 NICE Clinical Guidance 95 A63 89 Pulmonary Hypertension A88, A147 125, E Length of Stay A74, A77, A4, A68 105, 108, 5, NICE guidelines A10 16 PVAT A128 188 96 NICOR A5 6 Lipid profile A62 86 nitric oxide A130 192 QTc evaluation A109 150 Lipoproteins A125 181 Nocturnal A66 92 Quality Improvement A55 76 liver dysfunction A6 8 Noradrenaline A135 201 quality of life A112 156 local anaesthesia A32 44 Nox2 A114 159 long detection-time A37 51 NP concentration A12 19 radial artery A22 32

Heart 2016;102(Suppl 6):A1–A156 A149 Subject index

Randomised controlled trial A65 91 ST-Elevation Myocardial Infarction A70, A81, A81 Transcatheter aortic valve implantation A26, A27, Rapid Access Chest Pain Clinic A63 89 100, 114, 115 A33 37, 39, 46 Readmission A12 18 Stem cells A118 168 transcatheter A32, A32 44, Referral Pathway A9 14 STEMI A78, A17, A24, A68 111, 26, 35, 97 45 Refractory angina A65 91 steroids A119 170 Transoesophageal echocardiography A47 65 relationship A7 11 Strain Imaging A83, A85, A89 119, 120, 126 transseptal A41 56 Remodelling A102, A120 142, 171 strain-volume loop A110 152 Trisomy 21 A52 72 Remote A43 59 Strategy A18 27 troponin A79, A106, A62 112, 147, 88 renal dysfunction A6 7 stress echocardiography A93, A94 131, 132 Type 2 Myocardial Infarction A80 113 renal morphology A125 180 Stroke A35, A45 49, 62 Reprogramming A134 200 STS A31 43 UK outpatients A58 80 response A39 55 Sudden Cardiac Death A86, A104, A106, A112 Unstable coronary artery disease A78 110 Resting Indices A19 29 121, 145, 148, 155 resuscitation A75 106 Sudden death A48, A49 66, 67 Vagus nerve stimulation A142 215 Revascularisation A23, A62 33, 87 Supravalvular aortic stenosis A135 203 valve disease A110 152 Right atrial flow pattern A97 137 Surgery, A112 154 Vascular Biology A122 175 Risk assessment A59 82 surgical ablation A47 64 vascular calcification A122, A132 177, 196 Risk Prediction A34 47 sweetened beverage A61 85 vascular endothelial growth factor A133 198 risk score A64 90 Sympathetic nervous system A142 215 vascular injury A22 32 Risk Stratification A73 104 Syncope A50 70 Vascular smooth muscle A135 201 rule-out A72 103 systematic review A2 3 vascular smooth muscle cell A121 174 ryanodine receptor A123 178 systemic lupus erythematosus A122 177 vascular smooth muscle cells A121, A132 173, 197 Systolic Function A113 158 Vasodilation A129 189 Same-day discharge A37 52 vasoregulation A125 182 Sapien 3 valve A32 45 TAVI A28, A30, A34 40, 42, 47 Vectorcardiography A67 95 Sarcopenia A2 2 Telemedicine A11 17 venous congestion A6 7 Savings A12 18 Telemetry A41 57 Venous Thromboembolism A55 76 screening A113 157 Third coronary artery A141 213 Ventilatory product A54 74 Shear stress A130, A140 191, 211 Thrombolysis A70 100 Ventricular function A98 138 smooth muscle cells A146 B thrombosis A127, A69 186, 98 Ventricular tachycardia A49 68 SMURF1 A147 E thrombosis mouse model A118 169 vessel perfusion A125 182 soft drinks A61 85 Thrombus aspiration A24 35 von Willebrand factor A143 216 soluble guanylate cyclase A118 169 Timing A23 33 Spinal cord stimulation A65 91 Tissue engineeing A116 164 Wall Shear Stress A126 183 ST elevation A105 146 Titin A102, A103 142, 143 Weekend A44 60 Stable IHD A59 82 Tobacco Abusers A56 78 Weekend Discharge A3 4 tolvaptan A1 1 Whole exome sequencing A138 209

A150 Heart 2016;102(Suppl 6):A1–A156